1
|
Ecological Transition in the Field of Brake Pad Manufacturing: An Overview of the Potential Green Constituents. SUSTAINABILITY 2022. [DOI: 10.3390/su14052508] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
Nowadays, the drive for green products has undergone a rapid increase following the global ecoawareness and the severe regulations aimed at preventing the environment from further damage. The use of ecosafe constituents in materials for harsh applications, such as brake pad systems, can be a possible solution for reducing health hazards arising from particle release during braking. Based on this, the present study provides a bibliographic review of green alternative constituents for friction material formulation, focusing the attention on their influence on the tribological properties of the final composites. The traditional materials still used in commercial brake pads are shortly described, with the aim to provide an overview of the current situation. In the final part of the review, following the trend of circular economy, works dealing with the use of waste as an ingredient of friction materials are also reported. The whole literature screening points out that much work is still required to obtain completely green friction materials. Indeed, few works dealing with the phenolic resin replacement, proposing inorganic ecosafe materials such as geopolymers, are present. On the contrary, the use of natural fibers is widely investigated: palm kernel, flax, agave and aloe can be identified as promising constituents based on the literature results and the generated patents.
Collapse
|
2
|
Moitra S, Farshchi Tabrizi A, Idrissi Machichi K, Kamravaei S, Miandashti N, Henderson L, Mukherjee M, Khadour F, Naseem MT, Lacy P, Melenka L. Non-Malignant Respiratory Illnesses in Association with Occupational Exposure to Asbestos and Other Insulating Materials: Findings from the Alberta Insulator Cohort. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH 2020; 17:ijerph17197085. [PMID: 32998195 PMCID: PMC7579178 DOI: 10.3390/ijerph17197085] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 09/09/2020] [Revised: 09/25/2020] [Accepted: 09/25/2020] [Indexed: 12/23/2022]
Abstract
Many insulating materials are used in construction, although few have been reported to cause non-malignant respiratory illnesses. We aimed to investigate associations between exposures to insulating materials and non-malignant respiratory illnesses in insulators. In this cross-sectional study, 990 insulators (45 ± 14 years) were screened from 2011-2017 in Alberta. All participants underwent pulmonary function tests and chest radiography. Demographics, work history, and history of chest infections were obtained through questionnaires. Chronic obstructive pulmonary disease (COPD) was diagnosed according to established guidelines. Associations between exposures and respiratory illnesses were assessed by modified Poisson regression. Of those screened, 875 (88%) were males. 457 (46%) participants reported having ≥ 1 chest infection in the past 3 years, while 156 (16%) were diagnosed with COPD. In multivariate models, all materials (asbestos, calcium silicate, carbon fibers, fiberglass, and refractory ceramic fibers) except aerogels and mineral fibers were associated with recurrent chest infections (prevalence ratio [PR] range: 1.18-1.42). Only asbestos was associated with COPD (PR: 1.44; 95% confidence interval [CI]: 1.01, 2.05). Therefore, occupational exposure to insulating materials was associated with non-malignant respiratory illnesses, specifically, recurrent chest infections and COPD. Longitudinal studies are urgently needed to assess the risk of exposure to these newly implemented insulation materials.
Collapse
Affiliation(s)
- Subhabrata Moitra
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
| | - Ali Farshchi Tabrizi
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
| | - Kawtar Idrissi Machichi
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
| | - Samineh Kamravaei
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
| | - Noushin Miandashti
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
| | - Linda Henderson
- Synergy Respiratory & Cardiac Care, Sherwood Park, AB T8H 0N2, Canada; (L.H.); (F.K.); (M.T.N.)
| | - Manali Mukherjee
- Department of Medicine, McMaster University & Firestone Institute for Respiratory Health, St. Joseph’s Healthcare, Hamilton, ON L8N 4A6, Canada;
| | - Fadi Khadour
- Synergy Respiratory & Cardiac Care, Sherwood Park, AB T8H 0N2, Canada; (L.H.); (F.K.); (M.T.N.)
| | - Muhammad T. Naseem
- Synergy Respiratory & Cardiac Care, Sherwood Park, AB T8H 0N2, Canada; (L.H.); (F.K.); (M.T.N.)
| | - Paige Lacy
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
- Correspondence: ; Tel.: +1-780-492-6085
| | - Lyle Melenka
- Alberta Respiratory Centre, Department of Medicine, University of Alberta, Edmonton, AB T6G 2R3, Canada; (S.M.); (A.F.T.); (K.I.M.); (S.K.); (N.M.); (L.M.)
- Synergy Respiratory & Cardiac Care, Sherwood Park, AB T8H 0N2, Canada; (L.H.); (F.K.); (M.T.N.)
| |
Collapse
|
3
|
A comparison of the results from intra-pleural and intra-peritoneal studies with those from inhalation and intratracheal tests for the assessment of pulmonary responses to inhalable dusts and fibres. Regul Toxicol Pharmacol 2016; 81:89-105. [DOI: 10.1016/j.yrtph.2016.07.019] [Citation(s) in RCA: 18] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/07/2016] [Revised: 07/20/2016] [Accepted: 07/28/2016] [Indexed: 02/01/2023]
|
4
|
Maxim LD, Niebo R, Utell MJ, McConnell EE, LaRosa S, Segrave AM. Wollastonite toxicity: an update. Inhal Toxicol 2014; 26:95-112. [DOI: 10.3109/08958378.2013.857372] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
5
|
Morimoto Y, Ogami A, Todoroki M, Yamamoto M, Murakami M, Hirohashi M, Oyabu T, Myojo T, Nishi KI, Kadoya C, Yamasaki S, Nagatomo H, Fujita K, Endoh S, Uchida K, Yamamoto K, Kobayashi N, Nakanishi J, Tanaka I. Expression of inflammation-related cytokines following intratracheal instillation of nickel oxide nanoparticles. Nanotoxicology 2011; 4:161-76. [PMID: 20795893 DOI: 10.3109/17435390903518479] [Citation(s) in RCA: 63] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
Abstract
The objective of this study was to examine what kinds of cytokines are related to lung disorder by well-dispersed nanoparticles. The mass median diameter of nickel oxide in distilled water was 26 nm. Rats intratracheally received 0.2 mg of nickel oxide suspended in distilled water, and were sacrificed from three days to six months. The concentrations of 21 cytokines including inflammation, fibrosis and allergy-related ones were measured in the lung. Infiltration of alveolar macrophages was observed persistently in the nickel oxide-exposed group. Expression of macrophage inflammatory protein-1alpha showed a continued increase in lung tissue and broncho-alveolar lavage fluid (BALF) while interleukin-1alpha (IL-1alpha), IL-1beta in lung tissue and monocyte chemotactic protein-1 in BALF showed transient increases. Taken together, it was suggested that nano-agglomerates of nickel oxide nanoparticles have a persistent inflammatory effect, and the transient increase in cytokine expression and persistent increases in CC chemokine were involved in the persistent pulmonary inflammation.
Collapse
Affiliation(s)
- Yasuo Morimoto
- Institute of Industrial Ecological Sciences, University of Occupational and Environmental Health, Kitakyushu, Fukuoka, Japan.
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
6
|
Abstract
Wollastonite is a naturally occurring calcium silicate (CaSiO(3)) that is produced in both powder and fibrous forms. It is a valuable industrial mineral used in plastics, ceramics, metallurgical applications, paint, and friction products. For some applications wollastonite serves as an asbestos replacement. To varying degrees, wollastonite grades contain respirable particles/fibers, some of which have lengths and diameters that might be biologically active if deposited and retained in the lung. In this review we provide background information on wollastonite properties, markets, production and use, regulatory classification, and occupational exposure limits. We also summarize the available studies on the toxicology and epidemiology of wollastonite. We conclude that there is inadequate evidence for the carcinogenicity of wollastonite in animals and, based on strong evidence that wollastonite is not biopersistent, believe that a well-designed animal inhalation bioassay would have a negative result. The epidemiological evidence for wollastonite is limited, but does not suggest that workers are at significant risk of an increased incidence of pulmonary fibrosis, lung cancer, or mesothelioma. Morbidity studies have demonstrated a nonspecific increase in bronchitis and reduced lung function. It is prudent, however, to continue product stewardship efforts by wollastonite producers to control workplace exposures and to monitor scientific developments.
Collapse
Affiliation(s)
- L Daniel Maxim
- Everest Consulting Associates, Cranbury, New Jersey 08512, USA.
| | | |
Collapse
|
7
|
Kováciková Z, Hurbánková M, Tátrai E, Cerná S. Effect of intratracheal fibres exposure on the rat lung. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2005; 149:363-5. [PMID: 16601789 DOI: 10.5507/bp.2005.059] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/07/2023] Open
Abstract
The changes in antioxidant status of rat lung after intratracheal instillation of stone-wool and glass fibres were studied. The animals were exposed to 2 or 8 mg of fibres for 4 or 16 weeks, the bronchoalveolar lavage was performed and the activity of superoxide dismutase, glutathione peroxidase and the total amount of glutathione was estimated both in tissue and in cell free fraction of bronchoalveolar lavage and the ascorbic acid was determined in lung tissue. The results showed the higher burden by stone-wool. Most changes were detected in groups exposed to higher dose of fibres for shorter time period, the most sensitive parameter was superoxide dismutase. The lung tissue was studied also by light microscopy and transmission electron microscopy.
Collapse
|
8
|
Beno M, Hurbankova M, Dusinska M, Cerna S, Volkovova K, Staruchova M, Barancokova M, Kazimirova A, Kovacikova Z, Mikulecky M, Kyrtopoulos SA. Multinucleate cells (MNC) as sensitive semiquantitative biomarkers of the toxic effect after experimental fibrous dust and cigarette smoke inhalation by rats. ACTA ACUST UNITED AC 2005; 57:77-87. [PMID: 16089322 DOI: 10.1016/j.etp.2005.04.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Changes in the counts of binucleate (BNC) and multinucleate cells (MNC) in cell mixtures from lung tissue and bronchoalveolar lavage fluid (BALF) as well as in proportions of four types of BALF cells: Alveolar macrophages (AM), lymphocytes, polymorphonuclears (PMN), BNC and in total BALF protein were followed in a study comparing the toxicity of wollastonite with that of amosite asbestos in Fischer 344 rats. Both of the fibrous dusts were inhaled every second day at 30 or 60 mg/m3 air combined with daily exposure to cigarette smoke at 30 mg of total particulate matter (TPM)/m3 air for 1 h. The exposures lasted 175 days. Both, proportions of BNC as well as of MNC in lung cell mixtures rose significantly after exposure to cigarette smoke only. After inhalation of wollastonite the BNC proportions in all except the lower dust exposure group compared to controls showed a significant rise with the maximal factor value of 2.1 in the higher dust plus smoke exposure group. Wollastonite caused only marginal changes in MNC and other inflammation parameters. After inhalation of amosite at comparing to controls the proportion of BNC rose 8 times in the 30 mg/m3 and 11 times in the 60 mg/m3 exposure group, respectively. The effect of smoking was additive. The proportions of MNC were 39 times higher in the 30 mg/m3 and 41 times higher in the 60 mg/m3 amosite exposure group than in controls. In the higher exposure group the effect of smoking was synergic in that the MNC proportion rose about 58 times over control values from 0.05% up to about 3.0% (99% confidence interval--CI = 2.7-3.3%). The other followed inflammation parameters showed the presence of inflammation in the lung. It could be concluded that wollastonite at the same inhalation exposure concentration caused in rats less toxic effects than amosite, and, that the number of MNC, as well as BNC in lung cell mixtures and in BALF may serve as an important semiquantitative biomarker of inflammation.
Collapse
Affiliation(s)
- Milan Beno
- Slovak Medical University-Institute of Preventive and Clinical Medicine, SK-83303 Bratislava, Slovak Republic.
| | | | | | | | | | | | | | | | | | | | | |
Collapse
|